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ABSTRACT 
Medullary carcinoma is a rare breast carcinoma with a syncytial growth pattern and high-grade cytology. It can be 
difficult to diagnose and may be missed on conventional imaging as the findings may overlap with benign lesions i.e. 
fibroadenomas. The authors report a case of a 25-year-old female who presented with multifocal breast lumps diagnosed 
with medullary carcinoma and fibroadenomas. Imaging and pathological correlation with contrast-enhanced MRI are 
presented in the diagnosis of these lesions. © 2009 Biomedical Imaging and Intervention Journal. All rights reserved. 
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INTRODUCTION 
Medullary carcinoma of the breast is a rare subtype 
of invasive breast carcinoma with a high-grade 
cytology but has been reported to have a good 
prognosis. It is an uncommon type of invasive breast 
cancer accounting for 5 - 7% of all breast cancers, 
occurring most frequently in women in their late 40s 
and early 50s. It is also more common in women who 
have a BRCA1 mutation. Radiologically, it can be 
difficult to diagnose and may be missed as the imaging 
findings may overlap with benign lesions i.e. 
fibroadenomas on conventional mammography and 
ultrasonography. The authors report a case of a 25-
year-old female who presented with multifocal breast 
lumps diagnosed with medullary carcinoma and 
fibroadenomas. Imaging and pathological correlation 
with contrast-enhanced MRI are presented in the 
diagnosis of these lesions. This case highlights the 
usefulness of utilizing contrast-enhanced MRI in the 
characterization of multiple breast lesions when 
conventional imaging findings are equivocal. 
CASE REPORT 
A 25-year-old female presented to the Breast 
Physician in April 2007 with a 2-month history of a 
painless lump in the right breast. She had no associated 
nipple discharge or other constitutional symptoms. 
Physical examination revealed a 3 cm, non-mobile 
mass in the upper outer quadrant of the right breast. It 
was non-tender and the overlying skin was normal. 
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There was no axillary lymphadenopathy. Prior to this 
presentation, the patient first presented to a private 
medical center with bilateral breast lumps in 2002. A 
few of these lumps were surgically removed and 
histologically proven to be fibroadenomas. During this 
period, her maternal aunt had developed breast cancer 
and was undergoing treatment. 
Breast examination and ultrasound follow-up was 
performed every 12 months. She was symptom free 
until she developed a painful lump in the left breast in 
2004. As this lesion clearly demonstrated typical 
benign features characteristic of a fibroadenoma, the 
lesion was followed up with ultrasound and had 
remained essentially unchanged for the next 3 years. 
She subsequently developed a new lump in the right 
breast for which she presented to us. 
Ultrasound examination of the right breast 
demonstrated a well-circumscribed lobulated 
hypoechoic mass with smooth margins corresponding 
to the palpable lump at the 9 o’clock position (Figure 1). 
There were inhomogeneous internal echoes associated 
with posterior enhancement which was suggestive of 
proteinaceous materials or internal haemorrhage. 
Colour Doppler imaging showed some demonstrable 
internal vascularity. On the basis of these 
morphological features, the lesion was categorized as 
suspicious finding BI-RADS 4. The previously known 
stable nodule in the left breast had remained unchanged 
in size and appearance; however two new benign 
looking lesions had been identified. Bilateral 
mammograms was subsequently performed which was 
of limited diagnostic value due to the dense breast 
parenchymal pattern (Figure 2). No microcalcifications 
or axillary lymphadenopathy was demonstrated. The 
fine needle aspiration biopsy (FNAC) performed under 
ultrasound guidance was consistent with medullary 
carcinoma.  
Contrast-enhanced MRI (Siemens 1.5 Tesla), 
which was performed to exclude multifocal / 
multicentric carcinomas, showed a corresponding 
lobulated mass with smooth margins in the right upper 
outer quadrant. (Figure 3). The lesion was deep seated, 
lying adjacent to the pectoralis major with no evidence 
of infiltration into the underlying muscles. It 
demonstrated rapid homogenous enhancement in the 
early dynamic phase with an early washout pattern 
(Figure 4a). The other three nodules seen in the left 
outer quadrant showed gradual persistent enhancement 
throughout the dynamic study which were in favour of 
benign pathology (Figure 4b). The examination 
concluded the presence of a solitary right breast 
carcinoma with multiple left breast benign lesions. At 
the request of the surgeon, core biopsies were also 
performed on all the three lesions in the left breast 
under ultrasound guidance which were confirmed to be 
fibroadenomas. 
After discussing the treatment options with the 
patient, breast conservation surgery of the right breast 
with axillary clearance was performed in June 2007. 
Gross examination of the resected specimen revealed a 
smooth, well circumscribed solid mass measuring 
2.0 cm × 1.8 cm with bloody foci. It also had a fairly 
homogenous appearance with lack of dense fibrous 
stroma. Histopathological examination revealed 
lymphocytic infiltration with solid sheets of large 
 
Figure 1  Ultrasound examination of the right breast showing a well circumscribed hypoechoic mass (white 
arrow) with internal echogenicity and acoustic enhancement with lobulated margins. 
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Figure 2  Mammograms showed dense breast parenchymal pattern limiting the sensitivity of the examination. No 
suspicious masses, architectural distortion or microcalcifications were present. 
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Figure 3  MRI study of the breasts showing the medullary carcinoma in the right breast adjacent to the pectoralis 
muscle (long white arrow) appearing (a) isointense on T2W STIR axial (TR: 5450, TE: 60), (b) 
isointense on T1W fat sat axial sequence (TR: 11.2, TE: 5), (c) demonstrated homogenous enhancement 
during the early dynamic post-gadolinium sequence at 1 minute, and (d) delayed peripheral 
enhancement during the dynamic post-gadolinium at 6 minutes, suggestive of a malignant lesion. Note 
the smaller three enhancing fibroadenomas in the left breast (short white arrows) in (c) and (d), which 





 (a)  (b) 
Figure 4  Dynamic contrast-enhanced time intensity curves of (a) the right breast mass with early wash-in and 
early wash-out pattern, (b) the benign left breast lesions with gradual enhancement pattern throughout 
the dynamic phases. 
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anaplastic cells and syncytial growth consistent with 
medullary carcinoma (Figure 5). 
DISCUSSION 
Medullary breast carcinoma is a rare breast 
malignancy comprising less than 5% of breast 
carcinomas in majority of studies [1]. It has a 
predilection for women of a younger age group and in a 
study by Rosen et al. [2] it was found to constitute 11% 
of all breast malignancies among women aged 35 and 
younger. Some studies have revealed a similar degree 
of prognosis between medullary carcinoma and 
infiltrating ductal carcinoma of the same stage [3-5] 
whereas others have observed equal survival rates 
among these two types of carcinoma [6,7].  
Medullary carcinoma is a subtype of infiltrating 
ductal carcinoma. Therefore, the radiographic features 
are indistinguishable from the other tumours in the 
same subgroup. On gross examination, these groups of 
tumours are often well circumscribed with a median 
size of about 2.0-3.0 cm. It is a moderately firm, 
discrete tumour with a lobulated or nodular cut surface 
and may have necrosis or haemorrhagic changes [8]. 
Histologically, medullary carcinoma demonstrates 
syncytial growth pattern of poorly differentiated tumor 
cells with a high mitotic rate. Prominent lymphocytic 
infiltrates with a circumscribed microscopic appearance 
of desmoplastic inflammatory reaction involving 
mainly the periphery was also diffusely present 
throughout the substance of the tumor - this is another 
characteristic feature, which may account for its clinical 
and biological behaviour [9]. 
Normally, no glandular or fatty breast tissue 
should be found within the invasive portion of the 
tumour. IgG cells predominate with many T-
lymphocytes and more than 90% of these tumours are 
estrogen- and progesterone-receptor negative [9]. 
Histopathological examination in this patient revealed 
lymphocytic infiltration with solid sheets of large 
anaplastic cells and syncytial growth consistent with 
medullary carcinoma. Medullary carcinoma of the 
breast is considered to carry a more favourable or equal 
prognosis compared to other subtypes of infiltrating 
ductal carcinoma [9]. This is a biological paradox 
because its clinical behavior contrasts with its 
anaplastic morphology. The main characteristic feature 
of a medullary carcinoma is the dense lymphocytic 
infiltrate. The presence of increased numbers of 
activated cytotoxic lymphocytes in medullary 
carcinoma of the breast may be a key mechanism active 
in the host versus tumour response leading to improved 
prognosis. 
Based on several studies done previously, 
medullary carcinoma of the breast is usually described 
as an irregular shaped mass with microlobulation and 
least frequently with posterior acoustic shadowing 
sonographically [10]. Calcification is usually not 
present on mammographic imaging. Sonographic 
features of medullary carcinoma and other subtypes 
group do not differ substantially.  
In a study conducted by Cho and colleagues, they 
found that their cases of medullary carcinoma were 
larger with a greater L/AP ratios than the 
fibroadenomas [11]. Their medullary cancers were 
round or lobular in shape and demonstrated thick walls 
with anechoic cystic space. Medullary carcinomas 
generally demonstrate a lesser degree of sound 
 
Figure 5  Histopathology slide showing lymphocytic infiltration with solid sheets of large anaplastic cells with 
syncytial growth. 
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attenuation as compared to other malignant tumours on 
ultrasound. Other sonographic features include smooth 
contours, weak internal echoes and oval or round shape 
[12]. Typical fibroadenomas appear well circumscribed, 
homogeneous, hypoechoic with edge shadowing and 
gentle lobulations with occasionally coarse calcification 
within [13]. It is also a recognized fact that medullary 
carcinoma mimics a fibroadenoma sonographically [13].  
In this patient, the medullary carcinoma was 
shown on ultrasound to be a well-defined lobulated 
hypoechoic mass with posterior acoustic enhancement, 
or increased through transmission deep to it. This 
finding may be due to a homogenous population of 
tumor cells in the mass that have few acoustic 
interfaces, which would facilitate the transmission 
rather than the reflection of ultrasound. On 
mammogram, medullary carcinoma commonly appears 
uniformly dense, round or oval, non-calcified and with 
lobulated margins [12]. The width of the lobulations 
measured at the base, ranged from 2 to 3 mm, in some 
cases larger, solitary or multiple indentations were 
noted [12]. Some lesions, exhibited a halo sign at 
mammography, which until recently was considered 
strong evidence of a benign lesion [12]. In this patient, 
the lesion was not visualised on mammogram due to 
the dense stromal pattern that had obviously obscured 
the cancer as well as the fibroadenomas. No axillary 
lymphadenopathy was seen in this patient either. 
Young et al. [8] have reported cases of bilateral 
medullary carcinomas in about 3-18% of patients as 
well as multicentric medullary carcinoma in one breast 
[8, 10]. In this case, MRI of both breasts was performed 
to rule out multiplicity as she had a total of 4 lesions in 
both breasts. However, only one malignant lesion was 
identified in the right breast. The washout enhancement 
pattern on the dynamic study combined with the lesion 
margin is regarded as a highly specific diagnostic tool 
in characterizing the lesion as malignant. Peripheral rim 
enhancement demonstrated in this lesion was also 
strongly associated with malignancy.  
The other lesions were shown to have benign MR 
features based on the morphology and pattern of 
enhancement. It is difficult to differentiate the different 
subtype of infiltrating ductal carcinoma based on MRI 
findings alone. Majority of the lesions showed a strong 
or moderate degree of enhancement with peripheral 
enhancement and an early washout enhancement 
pattern in the dynamic sequence [14]. However, there 
are no specific features to suggest medullary carcinoma 
based on these findings, therefore other supportive 
features like size of lesion, margin, lobulation and 
correlation with ultrasound and mammogram are useful 
supporting parameters [15, 16]. At the time of writing 
this article, the protocol of breast MR that had been 
used in the authors’ institution was as follows:  
1.  Axial T1W fat sat,  
2.  Axial T2W PD/STIR,  
3.  Sagittal T2W STIR,  
4.  Dynamic post-gadolinium T1W (Axial) study 
with 1 minute intervals,  
5.  Axial post-gadolinium T1W fat sat. 
Fibroadenomas are benign breast tumours that 
represent proliferative process in the ducts and are 
considered to be an aberration of the normal breast 
development. They are not considered to have any 
malignant potential. However, in a study done by 
Dupont et al, they found that the risk of invasive breast 
cancer was twice as likely to occur in patients with 
fibroadenomas [17]. The relative risk was also found to 
be higher in women who have atypical fibroadenomas, 
proliferative disease, or a familial history of breast 
cancer. Although there is no literature pertaining to the 
association of medullary carcinoma of the breast and 
fibroadenomas, this case illustrates an example of how 
a medullary carcinoma can mimic a fibroadenoma. 
Follow up and good clinical history correlation is 
recommended for any patients on follow up for 
fibroadenomas. Any fibroadenomas with significant 
increase in size or develops atypical features on follow 
up or measures more than 3-4 cm in diameter should be 
surgically excised and biopsied regardless of patient’s 
age and results of triple testing. [13]. In this case, the 
patient had a family history of breast carcinoma and 
multiple fibroadenomas, both of which were risk 
factors in the development of breast carcinoma. 
The 5-year survival rate for medullary carcinoma 
is approximately 78% [9]. Death secondary to this 
disease is only 10% though. The 20-year disease free 
survival for stage I and II patients is approximately 
95% and 61%, respectively [9]. Breast conservation 
surgery is the treatment of choice for lesions less than 
3.0 cm with no more than 3 nodes involved. A right 
breast conservation surgery and axillary clearance was 
done for this patient. She is currently on chemotherapy 
and is to be followed by course of radiotherapy. In 
conclusion, this case demonstrates the importance of 
MR correlation to characterize breast lesions and 
exclude multiplicity of malignant lesions before surgery. 
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